Endo-BCN-PEG4-Pomalidomide
Endo-BCN-PEG4-Pomalidomide is a PEG derivative composed of BCN, PEG4 and Pomalidomide. The BCN groupis very reactive with azide-tagged molecules. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc[1].
Product Specifications
UNSPSC
12352200
Hazard Statement
H302-H315-H319-H335
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
[H][C@]12C([C@@H]2COC(NCCOCCOCCOCCOCC(NC3=CC=CC(C(N4C5CCC(NC5=O)=O)=O)=C3C4=O)=O)=O)([H])CCC#CCC1
Molecular Formula
C34H42N4O11
Molecular Weight
682.72
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Pasieka A, et al. Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists? ChemMedChem. 2023 Oct 17;18 (20) :e202300422.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472050-100 1x 100 µL
Human Kappa Light Chain / IGKC (B-Cell Marker) (rKLC709), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
